Clinical Trial

Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants

Name: Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants — clinical trial record (NCT07372703)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind, placebo-controlled, single ascending-dose study to evaluate the safety, tolerability and pharmacokinetics characteristics of VV913 Capsules in healthy adults.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-05

Trial Details

NCT Number	NCT07372703
Lead Sponsor	Vigonvita Life Sciences
Conditions	Healthy Volunteers
Enrollment	56 participants
Start Date	2026-01-29
Primary Completion	2026-09 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2026-05-04